Search

Displaying results 9001 - 9010 of 10000 in total
  1. Drug

    Polydioxanone

    go.drugbank.com/drugs/DB14832
    Investigational

    Polydioxanone is under investigation in clinical trial NCT00998907 (PDS*Plus and Wound Infections After Laparotomy).

  2. Drug

    Tarloxotinib

    go.drugbank.com/drugs/DB14944
    Investigational

    Tarloxotinib is under investigation in clinical trial NCT03743350 (NSCLC Exon 20 or HER2-activating Mutations).

  3. Drug

    UK-500001

    go.drugbank.com/drugs/DB12837
    Investigational

    UK-500,001 has been used in trials studying the treatment of Pulmonary Disease, Chronic Obstructive.

  4. Drug

    LIS-1

    go.drugbank.com/drugs/DB18388
    Experimental

    LIS-1 is an immunoglobulin G (IgG) polyclonal antibody that binds to human T cells.

  5. Drug

    EXT608

    go.drugbank.com/drugs/DB18453
    Investigational

    EXT608 is a long-acting PTH derivative under investigation for the treatment of hyperparathyroidism.[L48270]

  6. Drug

    MUL001

    go.drugbank.com/drugs/DB18534
    Experimental

    MUL001 is live attenuated strain of _Salmonella typhimurium_ being investigated for the treatment of schwannomas.

  7. Drug

    Cytochrome C

    go.drugbank.com/drugs/DB18543
    Investigational

    Cytochrome C is a hemeprotein that plays a role in the mitochondrial electron-transport chain.

  8. Drug

    Masilukast

    go.drugbank.com/drugs/DB16227
    Investigational

    Masilukast is under investigation in clinical trial NCT01740986 (Safety and Efficacy of SA09012 in Asthma).

  9. Drug

    Naphthoquine

    go.drugbank.com/drugs/DB16249
    Investigational

    Naphthoquine is under investigation in clinical trial NCT01930331 (Safety, Tolerability, Pharmacokinetics and Efficacy of ARCO).

  10. Drug

    Elraglusib

    go.drugbank.com/drugs/DB16047
    Investigational

    Elraglusib is under investigation in clinical trial NCT04218071 (Actuate 1901: 9-ING-41 in Myelofibrosis).